Endocrine complications of cancer therapy

Pediatric Oncology

Volumn 2015, Issue , 2015, Pages 65-94

  Rose, Susan R ^a   Lawson, Sarah ^a   Burns, Karen ^a   Merchant, Thomas E ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DESMOPRESSIN; FOLLITROPIN RELEASING FACTOR; GROWTH HORMONE; LUTEINIZING HORMONE; METFORMIN; PROLACTIN; SOMATOMEDIN C; THYROTROPIN; VASOPRESSIN;

ARTICLE; BODY MASS; BONE MATURATION; CANCER RADIOTHERAPY; CANCER THERAPY; CORTICOTROPIN DEFICIENCY; DIABETES INSIPIDUS; DISEASE SURVEILLANCE; ENDOCRINE DISEASE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; OBESITY; OSTEOPENIA; PRIORITY JOURNAL; PUBERTY; SYMPTOM;

EID: 84976568977     PISSN: 16135318     EISSN: 21910812     Source Type: Book Series    
DOI: 10.1007/978-3-319-16435-9_5     Document Type: Article

References (83)

1. Agha A, Sherlock M, Brennan S et al (2005) Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab 90:6355-6360
2. Antonini A, Poewe W (2007) Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease. Lancet Neurol 6:826-829
3. Armstrong GT, Chow EJ, Sklar CA (2009) Alterations in pubertal timing following therapy for childhood malignancies. Endocr Dev 15:25-39
4. Bell J, Parker KL, Swinford RD et al (2010) Longterm safety of recombinant human growth hormone in children. J Clin Endocrinol Metab 95:167-177
5. Bereket A, Kiess W, Lustig RH et al (2012) Hypothalamic obesity in children. Obes Rev. doi: 10.1111/j.1467-789X.2012.01004.x
6. Bingham NC, Rose SR, Inge TH (2012) Bariatric surgery in hypothalamic obesity. Front Endocrinol (Lausanne) 3:23
7. Biro FM, Galvez MP, Greenspan LC et al (2010) Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls. Pediatrics 126:e583-e950
8. Blethen SL, Allen DB, Graves D et al (1996) Safety of recombinant deoxyribonucleic acid-derived growth hormone: the National Cooperative Growth Study experience. J Clin Endocrinol Metab 81:1704-1710
9. Boepple PA, Crowley WF Jr (1996) Precocious puberty. In: Adashi EY, Rock JA, Rosenwaks Z (eds) Reproductive endocrinology, surgery, and technology, vol 1. Lippincott-Raven, Philadelphia, p 989
10. Bourguignon JP, Pierard GE, Ernould C et al (1993) Effects of human growth hormone therapy on melanocytic naevi. Lancet 341:1505-1506
11. Carel JC, Ecosse E, Landier F et al (2012) Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study. J Clin Endocrinol Metab 97:416-425
12. Castaño JP, Delgado-Niebla E, Durán-Prado M et al (2005) New insights in the mechanism by which SRIF influences GH secretion. J Endocrinol Invest 28(5 Suppl):10-13
13. Chemaitilly W, Sklar CA (2010) Endocrine complications in long-term survivors of childhood cancers. Endocrinol Relat Cancer 17(3):R141-R159
14. Chrousos GP (1995) The hypothalamic-pituitaryadrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362
15. Cook DM, Rose SR (2012) A review of guidelines for use of growth hormone in pediatric and transition patients. Pituitary 15(3):301-310
16. Cummings DE, Merriam GR (2003) Growth hormone therapy in adults. Annu Rev Med 54:513-533
17. Darzy KH, Pezzoli SS, Thorner MO, Shalet SM (2005) The dynamics of growth hormone (GH) secretion in adult cancer survivors with severe GH deficiency acquired after brain irradiation in childhood for nonpituitary brain tumors: evidence for preserved pulsatility and diurnal variation with increased secretory disorderliness. J Clin Endocrinol Metab 90:2794-2803
18. Darzy KH, Shalet SM (2009) Hypopituitarism following radiotherapy. Pituitary 12:40-50
19. Elias AN, Gwinup G (1980) Effects of some clinically encountered drugs on steroid synthesis and degradation. Metabolism 29:582-592
20. Ergun-Longmire B, Mertens AC, Mitby P et al (2006) Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91:3494-3498
21. Eyal O, Sundararajan S, Inge TH, Rose SR (2006) Obesity in patients with craniopharyngioma. Endocrinologist 16:286-293
22. Ferretti E, Persani L, Jaffrain-Rea ML et al (1999) Evaluation of the adequacy of levothyroxine replacement in patients with central hypothyroidism. J Clin Endocrinol Metab 84:924-929
23. Fouladi M, Wallace D, Langston JW et al (2003) Survival and functional outcome of children with hypothalamic/ chiasmatic tumors. Cancer 97:1084-1092
24. Ghigo E, Aimaretti G, Corneli G (2008) Diagnosis of adult GH deficiency. Growth Horm IGF Res 18:1-16
25. Gilchrist FJ, Murray RD, Shalet SM (2002) The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults. Clin Endocrinol (Oxf) 57:363-370
26. Growth Hormone Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 85:3990-3993
27. Gurney JG, Ness KK, Sibley SD et al (2006) Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 107:1303-1312
28. Hartman ML, Xu R, Crowe BJ et al (2013) Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients. J Clin Endocrinol Metab 98:980-988
29. Hovi L, Saarinen-Pihkala UM, Vettenranta K et al (1999) Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. Bone Marrow Transplant 24:1131-1136
30. Inge TH, Pfluger P, Zeller M et al (2007) Gastric bypass for treatment of hypothalamic obesity after craniopharyngioma therapy. Nat Clin Pract Endocrinol Metab 3:606-609
31. Kaste SC, Rai SN, Fleming K et al (2006) Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 46:77-87
32. Kazlauskaite R, Evans AT, Villabona CV et al (2008) Corticotropin tests for hypothalamic-pituitary adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metab 93:4245-4253
33. Laughton SJ, Merchant TE, Sklar CA et al (2008) Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol 26:1112-1118
34. Lee KO, Persani L, Tan M et al (1995) Thyrotropin with decreased biological activity, a delayed consequence of cranial irradiation for nasopharyngeal carcinoma. J Endocrinol Invest 18:800-805
35. Lee PA, Klein K, Mauras N et al (2012) Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty. J Clin Endocrinol Metab 97:1572-1580
36. Leung W, Hudson MM, Strickland DK et al (2000) Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 18:3273-3279
37. Leung W, Rose SR, Zhou Y et al (2002) Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 20:2959-2964
38. Lustig RH, Post SR, Srivannaboon K et al (2003) Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88:611-616
39. May M, Rose SR (2007) Oral hydration during growth hormone stimulation with clonidine. J Pediatr Nurs 22:383-387
40. Mackenzie S, Craven T, Gattamaneni HR et al (2011) Long-term safety of growth hormone replacement after CNS irradiation. J Clin Endocrinol Metab 96:2756-2761
41. Merchant TE, Pritchard DL, Vargo JA, Sontag MR (2001) Radiation therapy for the treatment of childhood medulloblastoma: the rationale for current techniques, strategies, and dose-volume considerations. Electro Medica 69:69-71
42. Merchant TE, Kiehna EN, Sanford RA et al (2002) Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984-2001. Int J Radiat Oncol Biol Phys 53:533-542
43. Merchant TE, Zhu Y, Thompson SJ et al (2002) Preliminary results from a phase II trial of conformal radiation therapy for pediatric patients with localized low-grade astrocytoma and ependymoma. Int J Radiat Oncol Biol Phys 52:325-332
44. Merchant TE, Williams T, Smith JM et al (2002) Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function. Int J Radiat Oncol Biol Phys 54:45-50
45. Merchant TE, Kun LE, Krasin MJ et al (2008) Multiinstitution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average- risk medulloblastoma. Int J Radiat Oncol Biol Phys 70(3):782-787
46. Merchant TE, Rose SR, Bosley C et al (2011) Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. J Clin Oncol 29:4776-4780
47. Mericq MV, Eggers M, Avila A et al (2000) Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial. J Clin Endocrinol Metab 85:569-573
48. Midyett LK, Moore WV, Jacobson JD (2003) Are pubertal changes in girls before age 8 benign? Pediatrics 111:47-51
49. Molitch ME, Clemmons DR, Malozowski S et al (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1587-1609
50. Mostoufi-Moab S, Isaacoff EJ, Spiegel D et al (2013) Childhood cancer survivors exposed to total body irradiation are at significant risk for slipped capital femoral epiphysis during recombinant growth hormone therapy. Pediatr Blood Cancer 60:1766-1771
51. Nass R, Gaylinn BD, Thorner MO (2011) The role of ghrelin in GH secretion and GH disorders. Mol Cell Endocrinol 340:10-14
52. Neely EK, Lee PA, Bloch CA et al (2010) Leuprolide acetate 1-month depot for central precocious puberty: hormonal suppression and recovery. Int J Pediatr Endocrinol 2010:398639
53. Olshan JS, Willi SM, Gruccio D, Moshang T Jr (1993) Growth hormone function and treatment following bone marrow transplant for neuroblastoma. Bone Marrow Transplant 12:381-385
54. Rahhal S, Clarke WL, Kletter GB et al (2009) Results of a second year of therapy with the 12-month histrelin implant for the treatment of central precocious puberty. Int J Pediatr Endocrinol 2009:812517
55. Rose SR (1995) Isolated central hypothyroidism in short stature. Pediatr Res 38:967-973
56. Rose SR (2001) Cranial irradiation and central hypothyroidism. Trends Endocrinol Metab 12:97-104
57. Rose SR (2008) Mechanisms of hypothalamicpituitary injury in oncology survivors. Endocrinologist 18:85-89
58. Rose SR (2010) Clinical utility of time-of-day normal ranges for TSH. J Pediatr 157:662-667
59. Rose SR, Lustig RH, Pitukcheewanont P et al (1999) Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 84:4472-4479
60. Rose SR, Lustig RH, Burstein S et al (1999) Diagnosis of ACTH deficiency. Comparison of overnight metyrapone test to either low-dose or high-dose ACTH test. Horm Res 52:73-79
61. Rose SR, Municchi G (1999) Six-hour and four-hour nocturnal sampling for growth hormone. J Pediatr Endocrinol Metab 12:167-173
62. Rose SR, Schreiber RE, Kearney NS et al (2004) Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab 17:55-66
63. Rose SR, Danish RK, Kearney NS et al (2005) ACTH deficiency in childhood cancer survivors. Pediatr Blood Cancer 45:808-813
64. Roth C, Lakomek M, Schmidberger H, Jarry H (2001) Cranial irradiation induces premature activation of the gonadotropin-releasing-hormone. Klin Paediatr 213:239-243
65. Rottembourg D, O'Gorman CS, Urbach S et al (2009) Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma. J Pediatr Endocrinol Metab 22: 867-872
66. Sävendahl L, Maes M, Albertsson-Wikland K et al (2012) Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study. J Clin Endocrinol Metab 97:E213-E217
67. Shalitin S, Gal M, Goshen Y et al (2011) Endocrine outcome in long-term survivors of childhood brain tumors. Horm Res Paediatr 76:113-122
68. Sherlock M, Ayuk J, Tomlinson JW et al (2010) Mortality in patients with pituitary disease. Endocr Rev 31:301-342
69. Sørensen K, Mouritsen A, Aksglaede L et al (2012) Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty. Horm Res Paediatr 77:137-145
70. Spoudeas HA (2002) Growth and endocrine function after chemotherapy and radiotherapy in childhood. Eur J Cancer 38:1748-1759
71. Spoudeas HA, Charmandari E, Brook CG (2003) Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumors. Med Pediatr Oncol 40:224-229
72. Stava CJ, Jimenez C, Vassilopoulou-Sellin R (2007) Endocrine sequelae of cancer and cancer treatments. J Cancer Surviv 1:261-274
73. Steffensen C, Maegbaek ML, Laurberg P et al (2012) Heart valve disease among patients with hyperprolactinemia: a nationwide population-based cohort study. J Clin Endocrinol Metab 97:1629-1634
74. Swerdlow AJ, Reddingius RE, Higgins CD et al (2000) Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab 85:4444-4449
75. Taback SP, Dean HJ (1996) Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee. J Clin Endocrinol Metab 81:1693-1696
76. Tanner JM, Davies PS (1985) Clinical longitudinal standards for height and height velocity in North American children. J Pediatr 107:317-329
77. Toogood AA, Taylor NF, Shalet SM, Monson JP (2000) Modulation of cortisol metabolism by low- dose growth hormone replacement in elderly hypopituitary patients. J Clin Endocrinol Metab 85:1727-1730
78. Vance ML, Mauras N (1999) Growth hormone therapy in adults and children. N Engl J Med 341(16):1206-1216
79. Walvoord E (2009) Sex steroid replacement for induction of puberty in multiple pituitary hormone deficiency. Pediatr Endocrinol Rev 6(Suppl 2):298-305
80. Weismann D, Pelka T, Bender G et al (2012) Bariatric surgery for morbid obesity in craniopharyngioma. Clin Endocrinol (Oxf). doi: 10.1111/j.1365-2265.2012.04409.x
81. Wilson T, Rose SR, Rogol A et al (2003) Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 143:415-421
82. Yanovski JA, Rose SR, Municchi G et al (2003) Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N Engl J Med 348:908-917
83. Zemel BS, Leonard MB, Kelly A et al (2010) Height adjustment in assessing dual energy X-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95:1265-1273